74
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Developmental variations of plasma gamma-glutamyltransferase fractions in humans and in laboratory mammalians

, , , , , , , , , , , & show all
Pages 43-47 | Received 12 Sep 2011, Accepted 24 Oct 2011, Published online: 23 Dec 2011

References

  • el Yaagoubi M, Visvikis A, Siest G, Wellman M. (1995). Developmental- and tissue-specific DNA methylation patterns and expression of rat gamma-glutamyltransferase. Biochem Mol Biol Int 36:257–264.
  • Emdin M, Passino C, Michelassi C, Titta F, L’abbate A, Donato L, Pompella A, Paolicchi A. (2001). Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart j 22:1802–1807.
  • Emdin M, Pompella A, Paolicchi A. (2005). Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112:2078–2080.
  • Franzini M, Bramanti E, Ottaviano V, Ghiri E, Scatena F, Barsacchi R, Pompella A, Donato L, Emdin M, Paolicchi A. (2008a). A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis. Anal Biochem 374:1–6.
  • Franzini M, Corti A, Fornaciari I, Balderi M, Torracca F, Lorenzini E, Baggiani A, Pompella A, Emdin M, Paolicchi A. (2009a). Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT. Biomarkers 14:486–492.
  • Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, Glauber M, Pompella A, Paolicchi A. (2009b). Gamma-glutamyltransferase activity in human atherosclerotic plaques–biochemical similarities with the circulating enzyme. Atherosclerosis 202:119–127.
  • Franzini M, Fornaciari I, Siciliano G, Volpi L, Ricci G, Marchi S, Gagliardi G, Baggiani A, Torracca F, Fierabracci V, Miccoli M, Pompella A, Emdin M, Paolicchi A. (2010a). Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease. Clin Biochem 43:1246–1248.
  • Franzini M, Ottaviano V, Fierabracci V, Bramanti E, Zyw L, Barsacchi R, Scatena F, Boni C, Mammini C, Passino C, Pompella A, Emdin M, Paolicchi A. (2008b). Fractions of plasma gamma-glutamyltransferase in healthy individuals: reference values. Clin Chim Acta 395:188–189.
  • Franzini M, Paolicchi A, Fornaciari I, Ottaviano V, Fierabracci V, Maltinti M, Ripoli A, Zyw L, Scatena F, Passino C, Pompella A, Emdin M. (2010b). Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. Clin Chem Lab Med 48:713–717.
  • Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. (2003). Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49:1358–1366.
  • Lee DH, Jacobs DR Jr, Gross M, Steffes M. (2005). Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 51:1185–1191.
  • Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J, Tuomilehto J. (2006). Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart j 27:2170–2176.
  • Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomileto J. (2004). gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 89:5410–5414.
  • Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D’Agostino RB, Vasan RS. (2007). Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27:127–133.
  • Lim JS, Lee DH, Park JY, Jin SH, Jacobs DR Jr. (2007). A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem 53:1092–1098.
  • Lippi G, Targher G, Guidi GC. (2007). Relationship between gamma-glutamyltransferase, fasting plasma glucose, and triglycerides in the general population. Clin Chem 53:1866–7; author reply 1869.
  • Meisinger C, Döring A, Schneider A, Löwel H; KORA Study Group. (2006). Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189:297–302.
  • Mohan P, Ling SC, Watkins JB. (1994). Ontogeny of hepatobiliary secretion: role of glutathione. Hepatology 19:1504–1512.
  • Nemesánszky E, Lott JA. (1985). Gamma-glutamyltransferase and its isoenzymes: progress and problems. Clin Chem 31:797–803.
  • Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, Pompella A. (2004). Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 109:1440.
  • Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, Dominici S, Comporti M, Pompella A. (1999). Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation–a potential mechanism in atherosclerosis. J Investig Med 47:151–160.
  • Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H; Vorarlberg Health Monitoring and Promotion Program Study Group. (2005). Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130–2137.
  • Selvaraj P, Balasubramanian KA. (1985). Comparative structural and lectin-binding studies on gamma-glutamyltransferase from human adult liver, fetal liver and primary hepatoma. Eur J Biochem 153:485–490.
  • Targher G, Zoppini G, Lippi G, Guidi GC, Muggeo M. (2007). Effect of serum gamma-glutamyltransferase and obesity on the risk of dyslipidemia and poor glycemic control in type 2 diabetic patients: cross-sectional findings from the Verona Diabetes Study. Clin Chem 53:1867–9; author reply 1869.
  • Van Eyken P, Sciot R, Callea F, Van der Steen K, Moerman P, Desmet VJ. (1988a). The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology 8:1586–1595.
  • Van Eyken P, Sciot R, Desmet V. (1988b). Intrahepatic bile duct development in the rat: a cytokeratin-immunohistochemical study. Lab Invest 59:52–59.
  • Whitfield JB. (2001). Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38:263–355.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.